7Baggers
 Cocrystal Pharma reports Q3 EPS (19c) vs (49c) last year  TipRanks Fri, 14 Nov 2025 16:07:21 GMT
 Cocrystal (COCP) Plans 2026 Enrollment for Norovirus Study on CD  GuruFocus Fri, 14 Nov 2025 13:50:22 GMT
 Cocrystal Pharma Q3 loss narrows  MarketScreener Fri, 14 Nov 2025 13:09:54 GMT
 Cocrystal Pharma Reports Third Quarter 2025 Financial  GlobeNewswire Fri, 14 Nov 2025 13:00:00 GMT
 will breakout in cocrystal pharma inc. lead to full recovery  newser.com Thu, 06 Nov 2025 04:16:08 GMT
 Cocrystal Pharma Completes $1.03M Private Placement  TipRanks Thu, 30 Oct 2025 07:00:00 GMT

Cocrystal Pharma, Inc
(NASDAQ:COCP) 

COCP stock logo

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coro...

Founded: 2006
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends